155 related articles for article (PubMed ID: 25777043)
21. Response to Congly and Leise.
Praveen S; Chander SB
Am J Gastroenterol; 2014 Apr; 109(4):598-9. PubMed ID: 24698865
[No Abstract] [Full Text] [Related]
22. Polyethylene Glycol Versus Lactulose for Hepatic Encephalopathy: Do We Have a Clear Winner?
Giri S
J Clin Gastroenterol; 2022 Feb; 56(2):192. PubMed ID: 35104256
[No Abstract] [Full Text] [Related]
23. Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics.
Dasarathy S
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S50-3. PubMed ID: 15025256
[TBL] [Abstract][Full Text] [Related]
24. Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review.
Zucker DM; Redulla R
Gastroenterol Nurs; 2019; 42(1):84-94. PubMed ID: 30688711
[TBL] [Abstract][Full Text] [Related]
25. What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides?
Alfawaz HA; Aljumah AA
Saudi J Gastroenterol; 2012; 18(3):153-4. PubMed ID: 22626793
[No Abstract] [Full Text] [Related]
26. Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.
Rahimi RS; Rockey DC
Clin Liver Dis; 2015 Aug; 19(3):539-49. PubMed ID: 26195207
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
28. Use of Lactulose in Hepatic Encephalopathy: Is It Time to Shift Targets?
Sharma S; Chauhan A
Clin Gastroenterol Hepatol; 2022 May; 20(5):e1220-e1221. PubMed ID: 34058412
[No Abstract] [Full Text] [Related]
29. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.
Candy DC; Edwards D; Geraint M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):65-70. PubMed ID: 16819379
[TBL] [Abstract][Full Text] [Related]
30. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Alsahhar JS; Rahimi RS
Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
[TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
Huang E; Esrailian E; Spiegel BM
Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
[TBL] [Abstract][Full Text] [Related]
32. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
[No Abstract] [Full Text] [Related]
33. Improving treatments for hepatic encephalopathy.
Gastroenterol Nurs; 2012; 35(4):291-2. PubMed ID: 22847290
[No Abstract] [Full Text] [Related]
34. [Hepatic encephalopathy -- preventative effects of lactulose].
Z Gastroenterol; 2013 Aug; 51(8):708. PubMed ID: 24298621
[No Abstract] [Full Text] [Related]
35. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy.
Neff GW; Kemmer N; Zacharias VC; Kaiser T; Duncan C; McHenry R; Jonas M; Novick D; Williamson C; Hess K; Thomas M; Buell J
Transplant Proc; 2006 Dec; 38(10):3552-5. PubMed ID: 17175328
[TBL] [Abstract][Full Text] [Related]
36. Optimal treatment of hepatic encephalopathy.
Waghray A; Waghray N; Kanna S; Mullen K
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
[TBL] [Abstract][Full Text] [Related]
37. Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality.
Jia JD
J Gastroenterol Hepatol; 2012 Aug; 27(8):1262-3. PubMed ID: 22823914
[No Abstract] [Full Text] [Related]
38. Gut flora and hepatic encephalopathy in patients with cirrhosis.
Riordan SM; Williams R
N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
[No Abstract] [Full Text] [Related]
39. Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy?
Butt NI; Butt UI; Kakar AATK; Malik T; Siddiqui AM
J Coll Physicians Surg Pak; 2018 Feb; 28(2):115-117. PubMed ID: 29394969
[TBL] [Abstract][Full Text] [Related]
40. Can we ignore minimal hepatic encephalopathy any longer?
Qadri AM; Ogunwale BO; Mullen KD
Hepatology; 2007 Mar; 45(3):547-8. PubMed ID: 17326151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
